CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 260 filers reported holding CONMED CORP in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,857,450 | +30.8% | 205,000 | 0.0% | 0.66% | +30.5% |
| Q1 2023 | $21,291,300 | +17.2% | 205,000 | 0.0% | 0.51% | +16.2% |
| Q4 2022 | $18,171,200 | -2.7% | 205,000 | -12.0% | 0.44% | -9.3% |
| Q3 2022 | $18,680,000 | -12.5% | 233,000 | +4.5% | 0.48% | -22.4% |
| Q2 2022 | $21,354,000 | -29.0% | 223,000 | +10.1% | 0.62% | -18.0% |
| Q1 2022 | $30,081,000 | +4.8% | 202,500 | 0.0% | 0.76% | +14.2% |
| Q4 2021 | $28,706,000 | +35.0% | 202,500 | +24.6% | 0.66% | +48.3% |
| Q3 2021 | $21,260,000 | -4.8% | 162,500 | 0.0% | 0.45% | +1.4% |
| Q2 2021 | $22,332,000 | +101.0% | 162,500 | +91.0% | 0.44% | +82.2% |
| Q1 2021 | $11,111,000 | +27.2% | 85,085 | +9.1% | 0.24% | +30.8% |
| Q4 2020 | $8,736,000 | -38.3% | 78,000 | -56.7% | 0.18% | -48.5% |
| Q3 2020 | $14,161,000 | +9.3% | 180,000 | 0.0% | 0.36% | +1.1% |
| Q2 2020 | $12,958,000 | +25.7% | 180,000 | 0.0% | 0.36% | -16.7% |
| Q1 2020 | $10,309,000 | – | 180,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |